Alistair T Pagnamenta,Rauan Kaiyrzhanov,Yaqun Zou,Sahar I Da'as,Reza Maroofian,Sandra Donkervoort,Natalia Dominik,Marlen Lauffer,Matteo P Ferla,Andrea Orioli,Adam Giess,Arianna Tucci,Christian Beetz,Maryam Sedghi,Behnaz Ansari,Rita Barresi,Keivan Basiri,Andrea Cortese,Greg Elgar,Miguel A Fernandez-Garcia,Janice Yip,A Reghan Foley,Nicholas Gutowski,Heinz Jungbluth,Saskia Lassche,Tim Lavin,Carlo Marcelis,Peter Marks,Chiara Marini-Bettolo,Livija Medne,Ali-Reza Moslemi,Anna Sarkozy,Mary M Reilly,Francesco Muntoni,Francisca Millan,Colleen C Muraresku,Anna C Need,Andrea H Nemeth,Sarah B Neuhaus,Fiona Norwood,Marie O'Donnell,Mary O'Driscoll,Julia Rankin,Sabrina W Yum,Zarazuela Zolkipli-Cunningham,Isabell Brusius,Gilbert Wunderlich,Genomics England Research Consortium,Mert Karakaya,Brunhilde Wirth,Khalid A Fakhro,Homa Tajsharghi,Carsten G Bönnemann,Jenny C Taylor,Henry Houlden,John C Ambrose,Prabhu Arumugam,Emma L Baple,Marta Bleda,Freya Boardman-Pretty,Jeanne M Boissiere,Christopher R Boustred,Helen Brittain,Mark J Caulfield,Georgia C Chan,Clare E H Craig,Louise C Daugherty,Anna de Burca,Andrew Devereau,Rebecca E Foulger,Tom Fowler,Pedro Furió-Tarí,Joanne M Hackett,Dina Halai,Angela Hamblin,Shirley Henderson,James E Holman,Tim J P Hubbard,Kristina Ibáñez,Rob Jackson,Louise J Jones,Dalia Kasperaviciute,Melis Kayikci,Athanasios Kousathanas,Lea Lahnstein,Kay Lawson,Sarah E A Leigh,Ivonne U S Leong,Javier F Lopez,Fiona Maleady-Crowe,Joanne Mason,Ellen M McDonagh,Loukas Moutsianas,Michael Mueller,Nirupa Murugaesu,Peter O'Donovan,Chris A Odhams,Christine Patch,Mariana Buongermino Pereira,Daniel Perez-Gil,Dimitris Polychronopoulos,John Pullinger,Tahrima Rahim,Augusto Rendon,Pablo Riesgo-Ferreiro,Tim Rogers,Mina Ryten,Kevin Savage,Kushmita Sawant,Richard H Scott,Afshan Siddiq,Alexander Sieghart,Damian Smedley,Katherine R Smith,Samuel C Smith,Alona Sosinsky,William Spooner,Helen E Stevens,Alexander Stuckey,Razvan Sultana,Mélanie Tanguy,Ellen R A Thomas,Simon R Thompson,Carolyn Tregidgo,Emma Walsh,Sarah A Watters,Matthew J Welland,Eleanor Williams,Katarzyna Witkowska,Suzanne M Wood,Magdalena Zarowiecki

Abstract:The extracellular matrix comprises a network of macromolecules such as collagens, proteoglycans and glycoproteins. VWA1 (von Willebrand factor A domain containing 1) encodes a component of the extracellular matrix that interacts with perlecan/collagen VI, appears to be involved in stabilizing extracellular matrix structures, and demonstrates high expression levels in tibial nerve. Vwa1-deficient mice manifest with abnormal peripheral nerve structure/function; however, VWA1 variants have not previously been associated with human disease. By interrogating the genome sequences of 74 180 individuals from the 100K Genomes Project in combination with international gene-matching efforts and targeted sequencing, we identified 17 individuals from 15 families with an autosomal-recessive, non-length dependent, hereditary motor neuropathy and rare biallelic variants in VWA1. A single disease-associated allele p.(G25Rfs*74), a 10-bp repeat expansion, was observed in 14/15 families and was homozygous in 10/15. Given an allele frequency in European populations approaching 1/1000, the seven unrelated homozygote individuals ascertained from the 100K Genomes Project represents a substantial enrichment above expected. Haplotype analysis identified a shared 220 kb region suggesting that this founder mutation arose >7000 years ago. A wide age-range of patients (6-83 years) helped delineate the clinical phenotype over time. The commonest disease presentation in the cohort was an early-onset (mean 2.0 ± 1.4 years) non-length-dependent axonal hereditary motor neuropathy, confirmed on electrophysiology, which will have to be differentiated from other predominantly or pure motor neuropathies and neuronopathies. Because of slow disease progression, ambulation was largely preserved. Neurophysiology, muscle histopathology, and muscle MRI findings typically revealed clear neurogenic changes with single isolated cases displaying additional myopathic process. We speculate that a few findings of myopathic changes might be secondary to chronic denervation rather than indicating an additional myopathic disease process. Duplex reverse transcription polymerase chain reaction and immunoblotting using patient fibroblasts revealed that the founder allele results in partial nonsense mediated decay and an absence of detectable protein. CRISPR and morpholino vwa1 modelling in zebrafish demonstrated reductions in motor neuron axonal growth, synaptic formation in the skeletal muscles and locomotive behaviour. In summary, we estimate that biallelic variants in VWA1 may be responsible for up to 1% of unexplained hereditary motor neuropathy cases in Europeans. The detailed clinical characterization provided here will facilitate targeted testing on suitable patient cohorts. This novel disease gene may have previously evaded detection because of high GC content, consequential low coverage and computational difficulties associated with robustly detecting repeat-expansions. Reviewing previously unsolved exomes using lower QC filters may generate further diagnoses.

Biallelic variants in ARHGAP19 cause a motor-predominant neuropathy with asymmetry and conduction slowing

Neuropathy due to bi-allelic SH3TC2 variants: Genotype-phenotype correlation and natural history

An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy

Aberrant GlyRS-HDAC6 Interaction Linked to Axonal Transport Deficits in Charcot-Marie-Tooth Neuropathy

Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy

Genotype‐phenotype correlation in a novel ABHD12 mutation underlying PHARC syndrome

Identification of ALS5/SPG11/ KIAA1840 Mutations in Patients with Autosomal Recessive Form of Charcot-Marie-Tooth Disease Type 2 (S44.002)

Biallelic variants in cause a mitochondrial disorder primarily manifesting as peripheral neuropathy

Genetic and Clinical Features in 24 Chinese Distal Hereditary Motor Neuropathy Families

Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants

Genotype–phenotype correlations of AR‐CMT2S in a cohort of axonal Charcot–Marie–Tooth patients from Central South China

Assessment of Targeted Next-Generation Sequencing as a Tool for the Diagnosis of Charcot-Marie-Tooth Disease and Hereditary Motor Neuropathy

Genetic Risk of Axonal Neuropathy Following Infection

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

The genetic and clinical spectrum in a cohort of 39 families with complex inherited peripheral neuropathies

PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation

Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort

A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family

Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study

Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study

POLG1 mutations manifesting as autosomal recessive axonal Charcot-Marie-Tooth disease.